Anzeige
+++>>> Schnelle Produktionsaufnahme?: Multi-Tenbagger-Potenzial direkt in Spanien? <<<+++
GALAPAGOS GENOMICS WKN: A0EAT9 ISIN: BE0003818359 Kürzel: GLPG Forum: Aktien Thema: Hauptdiskussion
26,95 EUR
-1,68 %-0,46
3. May, 20:22:23 Uhr,
TTMzero RT
Kommentare 127
Summer.76,
30.10.2023 21:34 Uhr
0
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
https://www.glpg.com/press-release/3914/galapagos-concludes-strategic-evaluation-and-signs-letter-of-intent-to-transfer-jyseleca-business-to-alfasigma
Summer.76,
04.08.2023 6:20 Uhr
0
Galapagos GAAP EPS of €0.43, revenue of €328.8M
https://seekingalpha.com/news/3997161-galapagos-gaap-eps-of-043-revenue-of-3288m
• Galapagos press release (NASDAQ:GLPG): 1H GAAP EPS of €0.43.
• Revenue of €328.8M (+20.0% Y/Y).
Summer.76,
04.08.2023 6:20 Uhr
0
Galapagos announces first half-year 2023 financial results
https://www.glpg.com/press-release/3874/galapagos-announces-first-half-year-2023-financial-results
Summer.76,
04.05.2023 22:44 Uhr
0
Galapagos GAAP EPS of €0.40, revenue of €178.9M
https://seekingalpha.com/news/3965935-galapagos-gaap-eps-of-040-revenue-of-1789m
• Galapagos press release (NASDAQ:GLPG): Q1 GAAP EPS of €0.40.
• Revenue of €178.9M (+31.3% Y/Y).
• Current financial investments and cash and cash equivalents totaled €3,990.1 million on 31 March 2023, as compared to €4,094.1 million on 31 December 2022.
• We reiterate our full year 2023 cash burn guidance in the range of €380 and €420 million.
Summer.76,
03.05.2023 10:19 Uhr
0
https://www.finanznachrichten.de/nachrichten-2023-05/58975776-galapagos-nv-galapagos-announces-departure-of-bart-filius-chief-operating-officer-and-chief-financial-officer-399.htm
Summer.76,
31.03.2023 7:40 Uhr
0
Galapagos to transfer drug discovery and research activities in France to NovAliX
https://seekingalpha.com/news/3952944-galapagos-to-transfer-drug-discovery-and-research-activities-in-france-to-novalix
• Belgian biotech Galapagos NV (NASDAQ:GLPG) on Thursday said it would transfer its drug discovery and research activities in Romainville, France to contract research organization NovAliX.
• NovAliX will assume GLPG's research capabilities while GLPG will retain flexibility to access "necessary expertise and resources" through a five year-collaboration agreement, the company said in a statement.
• The move by GLPG comes as part of its strategic reset announced in 2022. The deal is expected to close in July this year.
• GLPG's employees in Romainville will also be transferred to NovAliX
• The company said the financial impact of the deal is included in its previously announced 2023 cash burn guidance in the range of €380M to €420M.
Summer.76,
31.03.2023 7:26 Uhr
0
https://www.glpg.com/press-release/3812/galapagos-and-novalix-enter-into-an-integrated-drug-discovery-collaboration
Waterboy,
30.03.2023 10:21 Uhr
0
Oder ?
Waterboy,
29.03.2023 15:24 Uhr
0
Also bekommst du das Unternehmen geschenkt …
Das ist doch verrückt 😜
Waterboy,
03.03.2023 13:43 Uhr
0
Wieviel Nettocash haben sie noch ?
Summer.76,
24.02.2023 5:50 Uhr
0
Galapagos reports FY 2022 results, sees further reduction of cash burn in FY 2023
https://seekingalpha.com/news/3940356-galapagos-reports-fy-2022-results-sees-further-reduction-of-cash-burn-in-fy-2023
• Galapagos press release (NASDAQ:GLPG): FY GAAP EPS of -€3.32 misses by €2.21.
• Revenue of €505.3M (+4.2% Y/Y) misses by €77M.
• For FY 2023, co anticipates further reduction of its cash burn and anticipates landing between €380 and €420 million (compared to €514 million for FY 2022).
• Anticipates between €140 and €160 million net sales of Jyseleca for FY 2023.
Summer.76,
24.02.2023 5:45 Uhr
0
Galapagos announces full year 2022 results and outlook for 2023
https://www.globenewswire.com/news-release/2023/02/23/2614774/0/en/Galapagos-announces-full-year-2022-results-and-outlook-for-2023.html
Summer.76,
23.01.2023 17:01 Uhr
0
Jefferies Upgrades Galapagos to Hold, Lowers Price Target to $47.2
https://www.benzinga.com/news/23/01/30518170/jefferies-upgrades-galapagos-to-hold-lowers-price-target-to-47-2
Jefferies analyst Peter Welford upgrades Galapagos (NASDAQ:GLPG) from Underperform to Hold and lowers the price target from $49 to $47.2.
Summer.76,
23.12.2022 8:33 Uhr
0
https://finance.yahoo.com/news/galapagos-announces-changes-executive-committee-210100169.html
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | TESLA MOTORS Hauptdiskussion | +0,19 % | |
2 | Jaguar Health für Investierte und Interessierte | +6,58 % | |
3 | Das neue Dax Prognose Forum | +0,51 % | |
4 | Aktien und Saunaclub alla Luci | ||
5 | GAMESTOP Hauptdiskussion | +12,36 % | |
6 | für alle, die es ehrlich meinen beim Traden. | ||
7 | STANDARD LITHIUM Hauptdiskussion | -4,85 % | |
8 | MICROSTRATEGY Hauptdiskussion | +8,27 % | |
9 | NVIDIA Hauptdiskussion | +2,63 % | |
10 | PAYPAL Hauptdiskussion | -2,24 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | TESLA MOTORS Hauptdiskussion | +0,41 % | |
2 | Jaguar Health für Investierte und Interessierte | +0,69 % | |
3 | GAMESTOP Hauptdiskussion | +12,47 % | |
4 | MICROSTRATEGY Hauptdiskussion | +8,27 % | |
5 | STANDARD LITHIUM Hauptdiskussion | -4,85 % | |
6 | NVIDIA Hauptdiskussion | +3,32 % | |
7 | PAYPAL Hauptdiskussion | -2,36 % | |
8 | Annovis Bio | -9,10 % | |
9 | Nantkwest / Immunitybio -> IBRX | -0,59 % | |
10 | Canopy Hauptforum | -1,75 % | Alle Diskussionen |